Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Acquisitions (2016 - 2023)

Fortress Biotech (FBIO) has 6 years of Acquisitions data on record, last reported at -$5.0 million in Q1 2023.

  • For Q1 2023, Acquisitions rose 75.0% year-over-year to -$5.0 million; the TTM value through Jun 2024 reached -$5.0 million, changed 0.0%, while the annual FY2022 figure was -$20.0 million, N/A changed from the prior year.
  • Acquisitions reached -$5.0 million in Q1 2023 per FBIO's latest filing, up from -$20.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at -$5.0 million in Q1 2023 and bottomed at -$20.0 million in Q1 2022.